- Home
- CTRA vs PODD Comparison
CTRA vs PODD Comparison
Compare CTRA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRA
- PODD
- Stock Information
- Founded
- CTRA 1989
- PODD 2000
- Country
- CTRA United States
- PODD United States
- Employees
- CTRA N/A
- PODD N/A
- Industry
- CTRA Oil & Gas Production
- PODD Medical/Dental Instruments
- Sector
- CTRA Energy
- PODD Health Care
- Exchange
- CTRA Nasdaq
- PODD Nasdaq
- Market Cap
- CTRA 17.5B
- PODD 16.5B
- IPO Year
- CTRA 1990
- PODD 2007
- Fundamental
- Price
- CTRA $25.56
- PODD $260.12
- Analyst Decision
- CTRA Strong Buy
- PODD Buy
- Analyst Count
- CTRA 17
- PODD 15
- Target Price
- CTRA $32.25
- PODD $251.53
- AVG Volume (30 Days)
- CTRA 6.3M
- PODD 609.1K
- Earning Date
- CTRA 10-31-2024
- PODD 11-07-2024
- Dividend Yield
- CTRA 3.28%
- PODD N/A
- EPS Growth
- CTRA N/A
- PODD 235.68
- EPS
- CTRA 1.65
- PODD 5.74
- Revenue
- CTRA $5,499,000,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- CTRA N/A
- PODD $22.33
- Revenue Next Year
- CTRA $15.89
- PODD $18.50
- P/E Ratio
- CTRA $15.49
- PODD $45.35
- Revenue Growth
- CTRA N/A
- PODD 27.42
- 52 Week Low
- CTRA $22.30
- PODD $160.19
- 52 Week High
- CTRA $28.90
- PODD $279.40
- Technical
- Relative Strength Index (RSI)
- CTRA 63.39
- PODD 63.27
- Support Level
- CTRA $22.60
- PODD $233.48
- Resistance Level
- CTRA $25.89
- PODD $276.57
- Average True Range (ATR)
- CTRA 0.62
- PODD 8.53
- MACD
- CTRA 0.21
- PODD 2.16
- Stochastic Oscillator
- CTRA 83.62
- PODD 63.19
About CTRA Coterra Energy Inc.
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and NGLs. The company's operations are primarily concentrated in three core operating areas; the Permian Basin in west Texas and southeast New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin in the Mid-Continent region in Oklahoma.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.